Work Medical Technology Group enters $200 million at-the-market share sale agreement

Published 24/11/2025, 23:42
Work Medical Technology Group enters $200 million at-the-market share sale agreement

Work Medical Technology Group (NASDAQ:WKMT) announced Monday that it has entered into a sales agreement with AC Sunshine Securities, LLC to offer and sell up to $200 million of its Class A ordinary shares through at-the-market offerings.

According to a statement in a press release, the agreement allows the company to sell shares from time to time at its discretion, with AC Sunshine Securities acting as sales agent. The company is not obligated to sell any shares under the agreement.

Under the terms of the deal, AC Sunshine Securities will use commercially reasonable efforts to sell the shares in accordance with the company’s instructions and applicable regulations. The company will pay the sales agent a commission of 3.5% of the aggregate gross proceeds from each sale and will reimburse certain specified expenses.

The shares will be offered and sold pursuant to a prospectus supplement dated November 21, 2025, to the company’s registration statement on Form F-3 (Registration Number 333-289943), filed on August 29, 2025, for a total offering amount of up to $200 million.

This information is based on a statement in a recent SEC filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.